Orrstown Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Orrstown Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-150	Closed	-$15K	–	222
2015 Q3	$15K	Sell	150 -204	-58%	-$24.5K	0.02%	141
2015 Q2	$44K	Hold	354	–	–	0.05%	128
2015 Q1	$41K	Hold	354	–	–	0.04%	127
2014 Q4	$36K	Sell	354 -1,800	-84%	-$175K	0.04%	135
2014 Q3	$196K	Sell	2,154 -306	-12%	-$26.9K	0.21%	84
2014 Q2	$211K	Sell	2,460 -1,104	-31%	-$87K	0.22%	75
2014 Q1	$281K	Sell	3,564 -639	-15%	-$53.2K	0.3%	75
2013 Q4	$318K	Sell	4,203 -960	-19%	-$68.1K	0.33%	74
2013 Q3	$361K	Sell	5,163 -3,033	-37%	-$199K	0.41%	70
2013 Q2	$475K	Buy	+8,196	New	+$474K	0.69%	53

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Orrstown Financial Services's IBB Position: Q4 2015 in Review

Orrstown Financial Services sold out of iShares Biotechnology ETF (IBB) in Q4 2015, closing a stake of 150 shares — an estimated $15K sold.

Orrstown Financial Services first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $475K in Q2 2013. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Orrstown Financial Services reported no remaining iShares Biotechnology ETF position as of Q4 2015 after selling out during the quarter.
Orrstown Financial Services sold 150 iShares Biotechnology ETF shares in Q4 2015, an estimated $15K.
Orrstown Financial Services first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
Orrstown Financial Services's iShares Biotechnology ETF position peaked at $475K in Q2 2013.
432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Orrstown Financial Services's 13F filing for Q4 2015, filed 22 Jan 2016.